Clinical Trial Update: Prevention and Treatment of Pyrrolitinib-associated Diarrhea [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update evaluating prevention and treatment of diarrhea associated with pyrrolitinib in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pyrrolitinib

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: UNKNOWN